购物车
- 全部删除
- 您的购物车当前为空
LR-90, an advanced glycation end product (AGE) inhibitor, is utilized in diabetic animal model research. This compound effectively suppresses inflammatory responses in human monocytes.
为众多的药物研发团队赋能,
让新药发现更简单!
LR-90, an advanced glycation end product (AGE) inhibitor, is utilized in diabetic animal model research. This compound effectively suppresses inflammatory responses in human monocytes.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 356 | 现货 | |
5 mg | ¥ 893 | 现货 | |
10 mg | ¥ 1,480 | 现货 | |
25 mg | ¥ 2,560 | 现货 | |
50 mg | ¥ 3,730 | 现货 | |
100 mg | ¥ 4,910 | 现货 | |
200 mg | ¥ 6,760 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,390 | 现货 |
产品描述 | LR-90, an advanced glycation end product (AGE) inhibitor, is utilized in diabetic animal model research. This compound effectively suppresses inflammatory responses in human monocytes. |
体外活性 | LR-90 (0、25、50、100 及 200 μM) 在S100b刺激24小时前1小时预处理后,显著且依剂量递减地阻断THP-1细胞对内皮细胞的黏附[1]。相同剂量的LR-90(24小时处理)对THP-1细胞的细胞活性无影响[1]。LR-90 (0、25、50、100 及 200 μM) 在S100b刺激4小时前1小时预处理后,依剂量递减地抑制THP-1细胞中RAGE、MCP-1、COX-2、IP-10及NOX2 mRNA的表达[1]。 |
体内活性 | LR-90 (50 mg/L) 能够减少肾脏中的AGE、AGER和脂质过氧化物[2]。通过口服给予LR-90(50 mg/L,持续27周)显著降低ZDF大鼠的血浆脂质,并对高血糖有轻微的影响[2]。 |
分子量 | 709.57 |
分子式 | C35H34Cl2N4O8 |
CAS No. | 245075-84-7 |
Smiles | CC(C)(Oc1ccc(NC(=O)Nc2ccc(Cc3ccc(NC(=O)Nc4ccc(OC(C)(C)C(O)=O)cc4)c(Cl)c3)cc2Cl)cc1)C(O)=O |
密度 | 1.448 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 95 mg/mL (133.88 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容